11–14 March Abarceo attended the ATTD in Barcelona.
Abarceo promoted its development to become the first company to provide the diabetes community with a drug that will adress major hallmarks of diabetes. That is including restoration of patients own insulin secretion, improved insulin sensitivity, long term efficacy from a daily, oral pill. There is no better insulin than your own.
Recent Comments